Toripalimab induces exacerbation of psoriasis in an esophageal cancer patient: a case report
{{output}}
Background: Toripalimab in combination with cisplatin and paclitaxel is indicated as a first-line treatment for metastatic esophageal squamous cell carcinoma (ESCC). Toripalimab, a PD-1 inhibitor, commonly causes immune-related a... ...
